,i #aahth ,,congress #ast ,session ,h4 ,r4 #dacd ,,in ,,the ,,house ,,of ,,representatives ,june #ad1 #bjbc,mr4 ,schiff 7for himself and ,ms4 ,kuster7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to direct the ,secretary of ,health and ,human ,services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,updated ,drug ,labeling for ,patient ,safety ,act4 #b4 ,safety labeling changes initiated by ,,anda holders 7a7 ,in general ,section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j77 is amended by adding at the end the following3 7#ad7 ,notwithstanding paragraph 7#b77;,a77v71 the ,secretary shall establish a process to allow the holder of an abbreviated new drug application to change the labeling of the drug that is the subject of the application to include new or updated safety-related information1 including a process to make such changes prior to being approved by the ,secretary4 4 7b7 ,regulations 7#a7 ,in general ,not later than #ah months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall issue a final rule to implement paragraph 7#ad7 of section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j771 as added by subsection 7a74 7#b7 ,contents ,the final rule issued under paragraph 7#a7 shall include a process for conforming the labeling of a drug that is labeled pursuant to such paragraph 7#ad71 the listed drug 7as such term is used in such section #eje7;j771 and other drugs approved under such section #eje7;j7 that reference such listed drug4 7#c7 ,effective date ,the final rule issued under paragraph 7#a7 shall become effective not later than #ahj days after the date on which such final rule is issued4